Healthcare
Health
Medical

LabCorp

4,259

$177.02
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$1.70 (+0.97%) Today
$0.00 (0.00%) As of 8:00 PM EDT after-hours

Why Robinhood?

You can buy or sell LabCorp and other stocks, options, ETFs, and crypto commission-free!

About LH

Laboratory Corporation of America Holdings, also called LabCorp, is a clinical laboratory company. The firm engages in the provision of clinical laboratory and end-to-end drug development services. Read More It operates through the following segments: LabCorp Diagnostics and Covance Drug Development. The LabCorp Diagnostics segment includes core testing as well as genomic and esoteric testing. The Covance Drug Development segment provides drug development solutions to companies in the pharmaceutical and biotechnology industries. The company was founded in 1971 and is headquartered in Burlington, NC.

CEO
Adam H. Schechter
Employees
65,000
Headquarters
Burlington, North Carolina
Founded
1971
Market Cap
17.21B
Price-Earnings Ratio
54.34
Dividend Yield
—
Average Volume
922.94K
High Today
$179.09
Low Today
$174.21
Open Price
$174.58
Volume
508.58K
52 Week High
$196.36
52 Week Low
$98.02

Collections

Healthcare
Health
Medical
Pharmaceutical
Biotechnology
US
North America

LH News

ReutersMay 28

LabCorp ties up with software provider to expand virtual clinical trials

(Reuters) - Laboratory Corporation of America Holdings (LabCorp) said on Thursday it was partnering with software provider Medable to speed up the adoption of v
15
ReutersMay 28

BRIEF-Labcorp To Adopt Decentralized Clinical Trials, Expand Technology Ecosystem

May 28 (Reuters) - Laboratory Corporation of America Holdings: * LABCORP ACCELERATES ADOPTION OF DECENTRALIZED CLINICAL TRIALS, EXPANDS TECHNOLOGY ECOSYSTEM TH
33

LH Earnings

$0.00
$0.98
$1.95
$2.93
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Q4 2019
Q1 2020
Q2 2020
Estimated
— per share
Actual
Expected Jul 23, Pre-Market

You May Also Like

GRN
MFG
YGRN
ANIP
KLR+
CETV
AGM-C
HSMV
VGR
NGLS-A
Robinhood Snacks newsletters and podcasts reflect the opinions of only the authors who are associated persons of Robinhood Financial LLC and do not reflect the views of Robinhood Markets, Inc. or any of its subsidiaries or affiliates. They are meant for informational purposes only, are not intended to serve as a recommendation to buy or sell any security in a self-directed Robinhood account or any other account, and are not an offer or sale of a security. They are also not research reports and are not intended to serve as the basis for any investment decision. Any third-party information provided therein does not reflect the views of Robinhood Markets, Inc., Robinhood Financial LLC, or any of their subsidiaries or affiliates. All investments involve risk and the past performance of a security or financial product does not guarantee future results or returns. Keep in mind that while diversification may help spread risk, it does not assure a profit or protect against loss. There is always the potential of losing money when you invest in securities or other financial products. Investors should consider their investment objectives and risks carefully before investing. The price of a given security may increase or decrease based on market conditions and customers may lose money, including their original investment. Robinhood Financial LLC, member FINRA/SIPC.

All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.

Buy LH

Market Price$177.02
Commissions$0.00
Estimated Cost
$0.00
Sign up for a Robinhood Account to buy or sell LabCorp stock and options commission-free.
LearnBlogCareersHelpLog InSign Up